Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

被引:62
|
作者
Oyanguren-Desez, Olatz [1 ,2 ,3 ]
Rodriguez-Antigueedad, Alfredo [4 ]
Villoslada, Pablo [5 ]
Domercq, Maria [1 ,2 ]
Alberdi, Elena [1 ,2 ,3 ]
Matute, Carlos [1 ,2 ,3 ]
机构
[1] Univ Basque Country, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Leioa 48940, Spain
[2] Univ Basque Country, Dept Neurociencias, Leioa 48940, Spain
[3] Neurotek, Zamudio, Spain
[4] Hosp Basurto, Serv Neurol, Bilbao, Spain
[5] Hosp Clin Barcelona, Barcelona, Spain
关键词
P2X7; receptors; Gene polymorphisms; Calcium permeability; Electrophysiology; Dye uptake; Multiple sclerosis; P2X(7) RECEPTOR; EXPRESSION; GLUTAMATE; OLIGODENDROCYTES; INHIBITION;
D O I
10.1016/j.ceca.2011.08.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates chronic experimental autoimmune encephalomyelitis. Here, we have explored the putative association of functionally relevant single nucleotide polymorphisms of the P2X7 receptor gene with multiple sclerosis. We found that T allele of rs17525809 polymorphism, which yields an Ala-76 to Val change in the extracellular domain, is more frequent in multiple sclerosis patients than in controls. Importantly, P2X7 variants with Val show a gain-of-function consisting in higher calcium permeability, larger electrophysiological responses and higher ethidium uptake, and enhance the effect of the also gain-of-function His-155 to Tyr substitution (rs208294) in the haplotype formed by these two variants. These findings may contribute to define the genetic background predisposing for multiple sclerosis and its pathophysiology. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 50 条
  • [21] P2X7 receptor induces gene expression
    Santos-Berríos, C
    Weisman, GA
    Gonzalez, FA
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 5 - 5
  • [22] Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
    Volonte, Cinzia
    Amadio, Susanna
    Liguori, Francesco
    Fabbrizio, Paola
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [23] P2X7: a target for neuroprotection and neuroinflammation in multiple sclerosis
    Gruber, R.
    Woodworth, L.
    Radzwilli, K.
    LaMorte, M.
    Pevarello, P.
    Ofengeim, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 695 - 695
  • [24] P2X7 Variants in Pathophysiology
    Pegoraro, Anna
    Grignolo, Marianna
    Ruo, Luigia
    Ricci, Ludovica
    Adinolfi, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [25] P2X7 Variants in Oncogenesis
    Pegoraro, Anna
    De Marchi, Elena
    Adinolfi, Elena
    CELLS, 2021, 10 (01) : 1 - 16
  • [26] Heteromerization between P2X7(a) and P2X7(k) splice variants
    Neblung, Conny
    Rabenstein, Jens
    Marschall, Viola
    Leon-Otegui, Miriam
    Nicke, Annette
    PURINERGIC SIGNALLING, 2010, 6 : 58 - 59
  • [27] The P2X7 Receptor
    Sluyter, Ronald
    PROTEIN REVIEWS, VOL 19, 2017, 1051 : 17 - 53
  • [28] Identification and characterization of a novel variant of the human P2X7 receptor resulting in gain of function
    Sun, Chengqun
    Chu, Jessica
    Singh, Sarita
    Salter, Russell D.
    PURINERGIC SIGNALLING, 2010, 6 (01) : 31 - 45
  • [29] Targeting P2X4 and P2X7 receptors in multiple sclerosis
    Domercq, Maria
    Matute, C.
    CURRENT OPINION IN PHARMACOLOGY, 2019, 47 : 119 - 125
  • [30] Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
    Guerini, Franca Rosa
    Agliardi, Cristina
    Bolognesi, Elisabetta
    Zanzottera, Milena
    Caputo, Domenico
    Pasanisi, Maria Barbara
    Rovaris, Marco
    Clerici, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)